首页> 外文期刊>Anti-cancer drugs >Dryofragin inhibits the migration and invasion of human osteosarcoma U2OS cells by suppressing MMP-2/9 and elevating TIMP-1/2 through PI3K/AKT and p38 MAPK signaling pathways
【24h】

Dryofragin inhibits the migration and invasion of human osteosarcoma U2OS cells by suppressing MMP-2/9 and elevating TIMP-1/2 through PI3K/AKT and p38 MAPK signaling pathways

机译:Dryofragin通过抑制MMP-2 / 9并通过PI3K / AKT和p38 MAPK信号通路提高TIMP-1 / 2来抑制人骨肉瘤U2OS细胞的迁移和侵袭

获取原文
获取原文并翻译 | 示例
           

摘要

Dryofragin, a phloroglucinol derivative extracted from Dryopteris fragrans (L.) Schott, was found to inhibit proliferation and induce apoptosis of tumor cells. However, the mechanism involved in the suppression of cancer cell metastasis by dryofragin remains unclear. Our study investigated the mechanisms for the antitumor properties of dryofragin on the migration and invasion of human osteosarcoma U2OS cells. Dryofragin suppressed the migration and invasive ability of U2OS cells, and it decreased the expression of MMP-2 and MMP-9 and elevated the expression of TIMP-1 and TIMP-2. Western blotting assays indicated that dryofragin was effective in suppressing the phosphorylation of phosphatidylinositide-3 kinase (PI3K), Akt, and p38 MAPK. These results suggest that dryofragin inhibited U2OS cell migration and invasion by reducing the expression of MMP-2 and MMP-9 and elevating the expression of TIMP-1 and TIMP-2 through the PI3K/AKT and p38 MAPK signaling pathways. Above all, we conclude that dryofragin represents an anti-invasive agent and may potentially be applicable in osteosarcoma therapy. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.
机译:发现从干燥鳞翅目(Dryopteris fragrans(L.)Schott)提取的间苯三酚衍生物Dryofragin抑制肿瘤细胞的增殖并诱导其凋亡。但是,干法菌素抑制癌细胞转移的机制尚不清楚。我们的研究探讨了干性氟蛋白对人骨肉瘤U2OS细胞迁移和侵袭的抗肿瘤机制。 Dryofragin抑制U2OS细胞的迁移和侵袭能力,降低MMP-2和MMP-9的表达并提高TIMP-1和TIMP-2的表达。蛋白质印迹分析表明,干燥的弗拉金蛋白可有效抑制磷脂酰肌醇3激酶(PI3K),Akt和p38 MAPK的磷酸化。这些结果表明,干素蛋白通过PI3K / AKT和p38 MAPK信号通路降低MMP-2和MMP-9的表达并提高TIMP-1和TIMP-2的表达,从而抑制了U2OS细胞的迁移和侵袭。最重要的是,我们得出的结论是,干燥的弗拉金蛋白代表一种抗侵入剂,并且可能潜在地适用于骨肉瘤治疗。版权所有(C)2016 Wolters Kluwer Health,Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号